Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...
Draft guidance issued for consultation recommends the use of four AI technologies to help professionals detect fractures in ...
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
The updated guideline recommends offering a comprehensive falls assessment and management for people who have fallen in the ...
A list of downloadable documents created during development.
In development GID-IND10275 Expected publication date: 27 November 2024 Register as a stakeholder ...
In development GID-IND10278 Expected publication date: 27 November 2024 Register as a stakeholder ...
In development GID-IND10273 Expected publication date: 27 November 2024 Register as a stakeholder ...
In development GID-IND10274 Expected publication date: 27 November 2024 Register as a stakeholder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback